mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.08 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |